Press Release BioNxt Advances Cladribine Clinical Program with Completion of the Investigational Medicinal Product Dossier (IMPD) Ahead of Human Clinical Studies Aug 19
Press Release BioNxt Provides Development, Intellectual Property and Commercial Update Across Sublingual Drug Delivery Pipeline Aug 17